Literature DB >> 9860271

Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.

C Leranth1, J R Sladek, R H Roth, D E Redmond.   

Abstract

This study investigated the question of whether grafted dopamine cells in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys form synapses and, if they do, whether their postsynaptic targets were the same as those in control monkeys or in previous studies in rats. Electron-microscopic single immunostaining was performed for tyrosine hydroxylase on vibratome sections prepared from the head of the caudate nucleus of controls and MPTP-treated African green monkeys (Cercopithecus aethiops sabaeus) that received a graft. Furthermore, correlated light- and electron-microscopic double immunostaining was carried out for tyrosine hydroxylase and calbindin in the same brain area of MPTP-treated plus grafted animals. In control monkeys, the majority (97%) of dopamine boutons terminate on spines that were also synaptic targets of immunonegative boutons forming asymmetric synaptic contacts: synaptic triads. In MPTP-treated, grafted animals, the majority of transplanted dopamine cells terminate on dendritic shafts (67%) and somata (32%), and only a few (1.33%) form axospine synapses. The results of the double immunostaining experiments indicated that these newly formed axosomatic and axodendritic synapses are associated with calbindin-immunoreactive, medium-sized, spiny striatonigral projection neurons. These observations indicate that: (1) dopamine from transplanted embryonic tissue acts via synaptic contacts on host neurons; (2) the primary synaptic targets of transplanted dopamine cells are not spines but dendrites and somata of host neurons; (3) these target neurons are the same as in control animals; and (4) comparing these observations with results of control and grafted rats, there are major species differences between rats and monkeys in the dopamine innervation of both control and transplanted animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860271     DOI: 10.1007/s002210050575

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  11 in total

1.  The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

Authors:  K E Soderstrom; G Meredith; T B Freeman; S O McGuire; T J Collier; C E Sortwell; Qun Wu; K Steece-Collier
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

2.  Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

Authors:  C Leranth; R H Roth; J D Elsworth; F Naftolin; T L Horvath; D E Redmond
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

Authors:  Timothy J Collier; Jennifer O'Malley; David J Rademacher; Jennifer A Stancati; Kellie A Sisson; Caryl E Sortwell; Katrina L Paumier; Kibrom G Gebremedhin; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

4.  Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates.

Authors:  John D Elsworth; J David Jentsch; Catherine A Vandevoort; Robert H Roth; D Eugene Redmond; Csaba Leranth
Journal:  Neurotoxicology       Date:  2013-01-18       Impact factor: 4.294

5.  Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF.

Authors:  D E Redmond; J D Elsworth; R H Roth; C Leranth; T J Collier; B Blanchard; K B Bjugstad; R J Samulski; P Aebischer; J R Sladek
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

Review 6.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

7.  Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.

Authors:  Katherine E Soderstrom; Jennifer A O'Malley; Nathan D Levine; Caryl E Sortwell; Timothy J Collier; Kathy Steece-Collier
Journal:  Eur J Neurosci       Date:  2010-01-25       Impact factor: 3.386

Review 8.  Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?

Authors:  Daniella Rylander Ottosson; Emma Lane
Journal:  Front Cell Neurosci       Date:  2016-02-08       Impact factor: 5.505

9.  Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic.

Authors:  Natosha M Mercado; Timothy J Collier; Thomas Freeman; Kathy Steece-Collier
Journal:  J Clin Cell Immunol       Date:  2016-12-06

10.  Cell therapy for Parkinson's disease: Why it doesn't work every time.

Authors:  Timothy J Collier; Caryl E Sortwell; Natosha M Mercado; Kathy Steece-Collier
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.